P. Brogna - Vol. 8, March 2002, Issue 1
Testo Immagini Bibliografia Summary Indice
1 Tollefson GD, Beasley CM, Tran PV, Street JS, Krueger JA, Tamura RN, et al. Olanzapine versus Haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997;154:457-65.
2 Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Andersen SW, Beasley C, et al. Double-Blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997;17:407-18.
3 Beasley CM Jr, Hamilton SH, Crawford AM, Dellva MA, Tollefson GD, Tran PV, et al. Olanzapine versus haloperidol: acute phase results of the international doubleblind olanzapine trial. Eur Neuropsychopharmacol 1997;7:125-37.
4 Tollefson GD, Andersen SW, Tran PV. The courseof depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone. Biol Psychiatry 1999;46:365-73.
5 Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, et al. A novel augmentation strategyfor treating resistant major depression. Am J Psychiatry 2001;158:131-4.
6 Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled Study. Arch Gen Psychiatry 2000;57:841-9.
7 Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999;14:339-43.
8 Breier A. Intramuscolar olanzapine safe and effective for bipolar mania. J Clin Psychopharmacol 2001;21:389-97.